Abercrombie & Fitch Co has a consensus price target of $145.73 based on the ratings of 13 analysts. The high is $215 issued by Jefferies on May 29, 2024. The low is $35 issued by B. Riley Securities on May 25, 2022. The 3 most-recent analyst ratings were released by Citigroup, UBS, and Morgan Stanley on May 30, 2024, respectively. With an average price target of $185 between Citigroup, UBS, and Morgan Stanley, there's an implied 13.90% upside for Abercrombie & Fitch Co from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/11/2024 | Buy Now | — | Argus Research | Kristina Ruggeri | — | Downgrade | Buy → Hold | Get Alert |
05/30/2024 | Buy Now | 16.98% | Citigroup | Paul Lejuez | $150 → $190 | Maintains | Neutral | Get Alert |
05/30/2024 | Buy Now | 18.83% | UBS | Mauricio Serna | $155 → $193 | Maintains | Neutral | Get Alert |
05/30/2024 | Buy Now | 5.9% | Morgan Stanley | Alexandra Steiger | $112 → $172 | Maintains | Equal-Weight | Get Alert |
05/30/2024 | Buy Now | 28.06% | Telsey Advisory Group | Dana Telsey | $152 → $208 | Maintains | Outperform | Get Alert |
05/29/2024 | Buy Now | 2.82% | JP Morgan | Matthew Boss | $144 → $167 | Maintains | Neutral | Get Alert |
05/29/2024 | Buy Now | 32.37% | Jefferies | Corey Tarlowe | $155 → $215 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | -6.42% | Telsey Advisory Group | Dana Telsey | $152 → $152 | Maintains | Outperform | Get Alert |
05/23/2024 | Buy Now | -6.42% | Telsey Advisory Group | Dana Telsey | $152 → $152 | Maintains | Outperform | Get Alert |
05/21/2024 | Buy Now | -7.65% | Citigroup | Paul Lejuez | $140 → $150 | Maintains | Neutral | Get Alert |
05/21/2024 | Buy Now | -4.57% | UBS | Mauricio Serna | $145 → $155 | Maintains | Neutral | Get Alert |
05/17/2024 | Buy Now | -11.34% | JP Morgan | Matthew Korn | $125 → $144 | Maintains | Neutral | Get Alert |
05/06/2024 | Buy Now | -31.04% | Morgan Stanley | Alexandra Steiger | $103 → $112 | Maintains | Equal-Weight | Get Alert |
04/11/2024 | Buy Now | -19.96% | Argus Research | Kristina Ruggeri | $97 → $130 | Maintains | Buy | Get Alert |
03/07/2024 | Buy Now | -13.8% | Citigroup | Paul Lejuez | $127 → $140 | Maintains | Neutral | Get Alert |
03/07/2024 | Buy Now | -36.58% | Morgan Stanley | Alexandra Steiger | $81 → $103 | Maintains | Equal-Weight | Get Alert |
03/07/2024 | Buy Now | -6.42% | Telsey Advisory Group | Dana Telsey | $140 → $152 | Maintains | Outperform | Get Alert |
03/06/2024 | Buy Now | -13.8% | Telsey Advisory Group | Dana Telsey | → $140 | Reiterates | Outperform → Outperform | Get Alert |
03/06/2024 | Buy Now | -4.57% | Jefferies | Corey Tarlowe | $149 → $155 | Maintains | Buy | Get Alert |
02/28/2024 | Buy Now | -13.8% | Telsey Advisory Group | — | $105 → $140 | Maintains | Outperform | Get Alert |
02/27/2024 | Buy Now | -21.81% | Citigroup | Paul Lejuez | $100 → $127 | Maintains | Neutral | Get Alert |
02/26/2024 | Buy Now | -19.96% | UBS | Mauricio Serna | $98 → $130 | Maintains | Neutral | Get Alert |
01/09/2024 | Buy Now | -38.43% | Citigroup | Paul Lejuez | $82 → $100 | Maintains | Neutral | Get Alert |
01/09/2024 | Buy Now | -35.35% | Telsey Advisory Group | Dana Telsey | $95 → $105 | Maintains | Outperform | Get Alert |
01/09/2024 | Buy Now | -39.66% | UBS | Jay Sole | $93 → $98 | Maintains | Neutral | Get Alert |
11/22/2023 | Buy Now | -49.51% | Citigroup | Paul Lejuez | $75 → $82 | Maintains | Neutral | Get Alert |
11/22/2023 | Buy Now | -53.82% | UBS | Jay Sole | $70 → $75 | Maintains | Neutral | Get Alert |
11/22/2023 | Buy Now | -58.13% | Morgan Stanley | Alexandra Steiger | $53 → $68 | Maintains | Equal-Weight | Get Alert |
11/22/2023 | Buy Now | -48.9% | Telsey Advisory Group | Dana Telsey | $74 → $83 | Maintains | Outperform | Get Alert |
11/21/2023 | Buy Now | -54.44% | Telsey Advisory Group | Dana Telsey | → $74 | Reiterates | Outperform → Outperform | Get Alert |
11/14/2023 | Buy Now | -54.44% | Telsey Advisory Group | Dana Telsey | $62 → $74 | Maintains | Outperform | Get Alert |
11/13/2023 | Buy Now | -56.9% | UBS | Jay Sole | $53 → $70 | Maintains | Neutral | Get Alert |
09/07/2023 | Buy Now | -61.83% | Telsey Advisory Group | Dana Telsey | $56 → $62 | Maintains | Outperform | Get Alert |
08/25/2023 | Buy Now | -68.6% | Morgan Stanley | Alexandra Steiger | $18 → $51 | Upgrade | Underweight → Equal-Weight | Get Alert |
08/24/2023 | Buy Now | -61.83% | JP Morgan | Matthew Korn | $45 → $62 | Maintains | Neutral | Get Alert |
08/24/2023 | Buy Now | -67.37% | UBS | Jay Sole | $42 → $53 | Maintains | Neutral | Get Alert |
08/24/2023 | Buy Now | -65.52% | Telsey Advisory Group | Dana Telsey | $47 → $56 | Maintains | Outperform | Get Alert |
08/23/2023 | Buy Now | -71.06% | Telsey Advisory Group | Dana Telsey | → $47 | Reiterates | Outperform → Outperform | Get Alert |
08/16/2023 | Buy Now | -71.06% | Telsey Advisory Group | Dana Telsey | $35 → $47 | Maintains | Outperform | Get Alert |
08/15/2023 | Buy Now | -72.29% | Citigroup | Paul Lejuez | $33 → $45 | Maintains | Neutral | Get Alert |
06/12/2023 | Buy Now | -74.76% | Argus Research | Taylor Conrad | → $41 | Upgrade | Hold → Buy | Get Alert |
05/25/2023 | Buy Now | -88.92% | Morgan Stanley | Alexandra Steiger | $17 → $18 | Maintains | Underweight | Get Alert |
05/25/2023 | Buy Now | -79.68% | Citigroup | Paul Lejuez | $24 → $33 | Maintains | Neutral | Get Alert |
05/25/2023 | Buy Now | -80.3% | UBS | Mauricio Serna | $28 → $32 | Maintains | Neutral | Get Alert |
05/25/2023 | Buy Now | -78.45% | Telsey Advisory Group | Dana Telsey | → $35 | Reiterates | Outperform → Outperform | Get Alert |
05/24/2023 | Buy Now | -78.45% | Telsey Advisory Group | Dana Telsey | → $35 | Reiterates | Outperform → Outperform | Get Alert |
05/18/2023 | Buy Now | -85.22% | Citigroup | Paul Lejuez | $32 → $24 | Maintains | Neutral | Get Alert |
05/17/2023 | Buy Now | -78.45% | Telsey Advisory Group | Dana Telsey | → $35 | Reiterates | Outperform → Outperform | Get Alert |
05/09/2023 | Buy Now | -81.53% | Jefferies | Corey Tarlowe | $35 → $30 | Maintains | Buy | Get Alert |
04/12/2023 | Buy Now | — | Argus Research | Taylor Conrad | — | Downgrade | Buy → Hold | Get Alert |
03/29/2023 | Buy Now | -82.76% | UBS | Jay Sole | $29 → $28 | Maintains | Neutral | Get Alert |
03/02/2023 | Buy Now | -80.3% | Citigroup | Paul Lejuez | $33 → $32 | Maintains | Neutral | Get Alert |
03/02/2023 | Buy Now | -82.76% | JP Morgan | Matthew Korn | $31 → $28 | Maintains | Neutral | Get Alert |
03/02/2023 | Buy Now | -89.53% | Morgan Stanley | Alexandra Steiger | $16 → $17 | Maintains | Underweight | Get Alert |
03/02/2023 | Buy Now | -82.15% | UBS | Mauricio Serna | $28 → $29 | Maintains | Neutral | Get Alert |
03/02/2023 | Buy Now | -78.45% | Telsey Advisory Group | Dana Telsey | $33 → $35 | Maintains | Outperform | Get Alert |
03/01/2023 | Buy Now | -79.68% | Telsey Advisory Group | Dana Telsey | → $33 | Reiterates | → Outperform | Get Alert |
02/23/2023 | Buy Now | -79.68% | Telsey Advisory Group | Dana Telsey | → $33 | Reiterates | → Outperform | Get Alert |
02/21/2023 | Buy Now | -79.68% | Citigroup | Paul Lejuez | $30 → $33 | Maintains | Neutral | Get Alert |
01/23/2023 | Buy Now | -81.53% | JP Morgan | Matthew Boss | $26 → $30 | Maintains | Neutral | Get Alert |
01/10/2023 | Buy Now | -82.76% | UBS | Mauricio Serna | $24 → $28 | Maintains | Neutral | Get Alert |
01/10/2023 | Buy Now | — | Morgan Stanley | Kimberly Greenberger | — | Assumes | → Underweight | Get Alert |
01/10/2023 | Buy Now | -79.68% | Telsey Advisory Group | Dana Telsey | $27 → $33 | Maintains | Outperform | Get Alert |
11/28/2022 | Buy Now | -90.15% | Morgan Stanley | Kimberly Greenberger | $15 → $16 | Maintains | Underweight | Get Alert |
11/23/2022 | Buy Now | -85.84% | Citigroup | Paul Lejuez | $19 → $23 | Maintains | Neutral | Get Alert |
11/23/2022 | Buy Now | -83.38% | Telsey Advisory Group | Dana Telsey | $25 → $27 | Maintains | Outperform | Get Alert |
10/31/2022 | Buy Now | -89.53% | JP Morgan | Matthew Boss | $20 → $17 | Maintains | Neutral | Get Alert |
08/31/2022 | Buy Now | -88.3% | Citigroup | Paul Lejuez | $21 → $19 | Maintains | Neutral | Get Alert |
08/30/2022 | Buy Now | -90.76% | Morgan Stanley | Kimberly Greenberger | $17 → $15 | Maintains | Underweight | Get Alert |
08/26/2022 | Buy Now | -84.61% | Telsey Advisory Group | Dana Telsey | $30 → $25 | Maintains | Outperform | Get Alert |
05/25/2022 | Buy Now | -78.45% | B. Riley Securities | Susan Anderson | $48 → $35 | Maintains | Buy | Get Alert |
05/25/2022 | Buy Now | -87.07% | UBS | Jay Sole | $34 → $21 | Maintains | Neutral | Get Alert |
05/25/2022 | Buy Now | -89.53% | Morgan Stanley | Kimberly Greenberger | $32 → $17 | Maintains | Underweight | Get Alert |
05/25/2022 | Buy Now | -81.53% | Telsey Advisory Group | Dana Telsey | $40 → $30 | Maintains | Outperform | Get Alert |
05/23/2022 | Buy Now | -81.53% | Citigroup | Paul Lejuez | $59 → $30 | Downgrade | Buy → Neutral | Get Alert |
05/16/2022 | Buy Now | -75.99% | JP Morgan | Matthew Boss | $35 → $39 | Maintains | Neutral | Get Alert |
03/03/2022 | Buy Now | -75.37% | Telsey Advisory Group | Dana Telsey | $45 → $40 | Maintains | Outperform | Get Alert |
01/11/2022 | Buy Now | -72.29% | Telsey Advisory Group | Dana Telsey | $55 → $45 | Maintains | Outperform | Get Alert |
01/07/2022 | Buy Now | -77.22% | UBS | Jay Sole | $68 → $37 | Downgrade | Buy → Neutral | Get Alert |
The latest price target for Abercrombie & Fitch (NYSE:ANF) was reported by Argus Research on July 11, 2024. The analyst firm set a price target for $0.00 expecting ANF to fall to within 12 months (a possible -100.00% downside). 40 analyst firms have reported ratings in the last year.
The latest analyst rating for Abercrombie & Fitch (NYSE:ANF) was provided by Argus Research, and Abercrombie & Fitch downgraded their hold rating.
The last upgrade for Abercrombie & Fitch Co happened on August 25, 2023 when Morgan Stanley raised their price target to $51. Morgan Stanley previously had an underweight for Abercrombie & Fitch Co.
The last downgrade for Abercrombie & Fitch Co happened on July 11, 2024 when Argus Research changed their price target from N/A to N/A for Abercrombie & Fitch Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Abercrombie & Fitch, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Abercrombie & Fitch was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.
While ratings are subjective and will change, the latest Abercrombie & Fitch (ANF) rating was a downgraded with a price target of $0.00 to $0.00. The current price Abercrombie & Fitch (ANF) is trading at is $162.42, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.